Detalhe da pesquisa
1.
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
Mult Scler
; 26(12): 1519-1531, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31573386
2.
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients.
FASEB J
; 32(8): 4241-4246, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29505299
3.
Assessment of the Corticospinal Tract Profile in Pure Lower Motor Neuron Disease: A Diffusion Tensor Imaging Study.
Neurodegener Dis
; 19(3-4): 128-138, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31715609
4.
The one-and-a-half syndrome: a distinctive clinical finding in a patient with multiple sclerosis.
Neurol Sci
; 44(9): 3331-3333, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099236
5.
The corticospinal tract profile in amyotrophic lateral sclerosis.
Hum Brain Mapp
; 38(2): 727-739, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659483
6.
An unusual ALS onset with hyperhidrosis as first clinical manifestation.
Neurol Sci
; 43(11): 6571-6572, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907109
7.
Opicapone-induced reversible myopathy in a patient with advanced Parkinson's disease and familial hyperCKemia.
Neurol Sci
; 42(6): 2583-2585, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495929
8.
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis.
Neurol Sci
; 41(Suppl 2): 491-492, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32845483
9.
A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association?
Neurol Sci
; 40(1): 195-197, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30215155
10.
Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables.
Neurotherapeutics
; 21(2): e00307, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237381
11.
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.
J Neurol
; 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704488
12.
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic.
J Neurol
; 270(2): 595-600, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229702
13.
Acute bulbar palsy without ophtalmoplegia associated with anti-GD3 IgM antibodies.
Neurol Sci
; 38(3): 521-523, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27837367
14.
Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study.
Pharmaceuticals (Basel)
; 15(2)2022 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35215330
15.
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature.
Rev Recent Clin Trials
; 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718981
16.
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic.
Neurotherapeutics
; 19(5): 1535-1545, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036858
17.
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study.
Neurotherapeutics
; 18(2): 1166-1174, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844155
18.
Listeria infection after treatment with alemtuzumab: a case report and literature review. Would antibiotic prophylaxis be considered?
Infez Med
; 28(2): 258-262, 2020 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487792
19.
Cladribine vs other drugs in MS: Merging randomized trial with real-life data.
Neurol Neuroimmunol Neuroinflamm
; 7(6)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801167
20.
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study.
Mult Scler Relat Disord
; 42: 102059, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208344